AKT1 and cancer: To explore the potential anticancer mechanisms of GeXIVA[1,2], we examined several cancer-associated pathways, including apoptosis, endoplasmic reticulum stress, AKT-mTOR signaling, MAPK signaling, NF-κB signaling, STAT3 signaling and so on.